ScoreWhy is Renhe Pharmacy Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -3.79% and Operating profit at -8.87% over the last 5 years
2
Flat results in Mar 26
- NET PROFIT(HY) At CNY 146.18 MM has Grown at -33.84%
- ROCE(HY) Lowest at 5.77%
- INVENTORY TURNOVER RATIO(HY) Lowest at 5.83 times
3
With ROE of 7.15%, it has a fair valuation with a 1.00 Price to Book Value
- Over the past year, while the stock has generated a return of -2.54%, its profits have fallen by -15.1%
- At the current price, the company has a high dividend yield of 2.9
4
Company is among the highest 1% of companies rated by MarketsMojo across all 4,000 stocks
5
Below par performance in long term as well as near term
- Along with generating -2.54% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Renhe Pharmacy Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Renhe Pharmacy Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Renhe Pharmacy Co., Ltd.
-16.48%
-0.68
27.49%
China Shanghai Composite
3.23%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-3.79%
EBIT Growth (5y)
-8.87%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.61
Sales to Capital Employed (avg)
0.65
Tax Ratio
28.69%
Dividend Payout Ratio
53.70%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
27.21%
ROE (avg)
11.84%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.08
EV to EBIT
5.45
EV to EBITDA
4.66
EV to Capital Employed
1.23
EV to Sales
0.78
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
22.49%
ROE (Latest)
7.15%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
CASH AND EQV(HY)
Highest at CNY 8,436.93 MM
EPS(Q)
Highest at CNY 0.11
-5What is not working for the Company
NET PROFIT(9M)
At CNY 272.21 MM has Grown at -21.56%
ROCE(HY)
Lowest at 6.18%
RAW MATERIAL COST(Y)
Grown by 5.27% (YoY
Here's what is working for Renhe Pharmacy Co., Ltd.
EPS
Highest at CNY 0.11
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Cash and Eqv
Highest at CNY 8,436.93 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Depreciation
Highest at CNY 29.8 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (CNY MM)
Depreciation
At CNY 29.8 MM has Grown at inf%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (CNY MM)
Here's what is not working for Renhe Pharmacy Co., Ltd.
Net Profit
At CNY 272.21 MM has Grown at -21.56%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
Raw Material Cost
Grown by 5.27% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
